Cargando…
Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum
BACKGROUND: The gonadotropin-releasing hormone (GnRH) analog buserelin causes enteric neuronal loss. Acute stress or injection of corticotropin-releasing factor (CRF) affects motility, secretion, and barrier function of the gastrointestinal tract. The aim of the study was to characterize the CRF imm...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693429/ https://www.ncbi.nlm.nih.gov/pubmed/26710832 http://dx.doi.org/10.1186/s13104-015-1800-x |
_version_ | 1782407388017459200 |
---|---|
author | Sand, Elin Linninge, Caroline Lozinska, Liudmyla Egecioglu, Emil Roth, Bodil Molin, Göran Weström, Björn Ekblad, Eva Ohlsson, Bodil |
author_facet | Sand, Elin Linninge, Caroline Lozinska, Liudmyla Egecioglu, Emil Roth, Bodil Molin, Göran Weström, Björn Ekblad, Eva Ohlsson, Bodil |
author_sort | Sand, Elin |
collection | PubMed |
description | BACKGROUND: The gonadotropin-releasing hormone (GnRH) analog buserelin causes enteric neuronal loss. Acute stress or injection of corticotropin-releasing factor (CRF) affects motility, secretion, and barrier function of the gastrointestinal tract. The aim of the study was to characterize the CRF immunoreactivity in enteric neurons after buserelin treatment, and to evaluate possible effects of enteric neuropathy on gut microbiota, intestinal permeability, and stress response behavior. RESULTS: Sixty rats were given buserelin (20 μg) or saline subcutaneously for 5 days, repeated four times with 3 weeks in-between. At the study end, enteric neuronal density, enteric expression of CRF, gut microbial composition, and plasma levels of adrenocorticotropic hormone (ACTH) and CRF were analyzed. Intestinal permeability was examined in Ussing chambers and the reaction to stressful events was measured by behavior tests. Buserelin treatment reduced the number of neurons along the entire gastrointestinal tract, with increased relative numbers of CRF-immunoreactive submucosal and myenteric neurons in colon (p < 0.05 and p < 0.01, respectively). The overall microbial diversity and relative abundance did not differ between groups, but Enterobacteriaceae was decreased in colon in buserelin-treated rats (p = 0.020). Basal intestinal permeability did not differ between groups, whereas carbachol stimulation increased ileum permeability in controls (p < 0.05), but not in buserelin-treated rats. Buserelin did not affect stress behavior. CONCLUSIONS: Although buserelin treatment leads to enteric neuronal loss along the gastrointestinal tract with an increased percentage of CRF-immunoreactive neurons in colon, the physiology is well preserved, with modest effects on colon microbiota and absence of carbachol-induced permeability in ileum as the only observed changes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13104-015-1800-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4693429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46934292015-12-30 Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum Sand, Elin Linninge, Caroline Lozinska, Liudmyla Egecioglu, Emil Roth, Bodil Molin, Göran Weström, Björn Ekblad, Eva Ohlsson, Bodil BMC Res Notes Research Article BACKGROUND: The gonadotropin-releasing hormone (GnRH) analog buserelin causes enteric neuronal loss. Acute stress or injection of corticotropin-releasing factor (CRF) affects motility, secretion, and barrier function of the gastrointestinal tract. The aim of the study was to characterize the CRF immunoreactivity in enteric neurons after buserelin treatment, and to evaluate possible effects of enteric neuropathy on gut microbiota, intestinal permeability, and stress response behavior. RESULTS: Sixty rats were given buserelin (20 μg) or saline subcutaneously for 5 days, repeated four times with 3 weeks in-between. At the study end, enteric neuronal density, enteric expression of CRF, gut microbial composition, and plasma levels of adrenocorticotropic hormone (ACTH) and CRF were analyzed. Intestinal permeability was examined in Ussing chambers and the reaction to stressful events was measured by behavior tests. Buserelin treatment reduced the number of neurons along the entire gastrointestinal tract, with increased relative numbers of CRF-immunoreactive submucosal and myenteric neurons in colon (p < 0.05 and p < 0.01, respectively). The overall microbial diversity and relative abundance did not differ between groups, but Enterobacteriaceae was decreased in colon in buserelin-treated rats (p = 0.020). Basal intestinal permeability did not differ between groups, whereas carbachol stimulation increased ileum permeability in controls (p < 0.05), but not in buserelin-treated rats. Buserelin did not affect stress behavior. CONCLUSIONS: Although buserelin treatment leads to enteric neuronal loss along the gastrointestinal tract with an increased percentage of CRF-immunoreactive neurons in colon, the physiology is well preserved, with modest effects on colon microbiota and absence of carbachol-induced permeability in ileum as the only observed changes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13104-015-1800-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-28 /pmc/articles/PMC4693429/ /pubmed/26710832 http://dx.doi.org/10.1186/s13104-015-1800-x Text en © Sand et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Sand, Elin Linninge, Caroline Lozinska, Liudmyla Egecioglu, Emil Roth, Bodil Molin, Göran Weström, Björn Ekblad, Eva Ohlsson, Bodil Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum |
title | Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum |
title_full | Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum |
title_fullStr | Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum |
title_full_unstemmed | Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum |
title_short | Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum |
title_sort | buserelin treatment to rats causes enteric neurodegeneration with moderate effects on crf-immunoreactive neurons and enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693429/ https://www.ncbi.nlm.nih.gov/pubmed/26710832 http://dx.doi.org/10.1186/s13104-015-1800-x |
work_keys_str_mv | AT sandelin buserelintreatmenttoratscausesentericneurodegenerationwithmoderateeffectsoncrfimmunoreactiveneuronsandenterobacteriaceaeincolonandinacetylcholinemediatedpermeabilityinileum AT linningecaroline buserelintreatmenttoratscausesentericneurodegenerationwithmoderateeffectsoncrfimmunoreactiveneuronsandenterobacteriaceaeincolonandinacetylcholinemediatedpermeabilityinileum AT lozinskaliudmyla buserelintreatmenttoratscausesentericneurodegenerationwithmoderateeffectsoncrfimmunoreactiveneuronsandenterobacteriaceaeincolonandinacetylcholinemediatedpermeabilityinileum AT egeciogluemil buserelintreatmenttoratscausesentericneurodegenerationwithmoderateeffectsoncrfimmunoreactiveneuronsandenterobacteriaceaeincolonandinacetylcholinemediatedpermeabilityinileum AT rothbodil buserelintreatmenttoratscausesentericneurodegenerationwithmoderateeffectsoncrfimmunoreactiveneuronsandenterobacteriaceaeincolonandinacetylcholinemediatedpermeabilityinileum AT molingoran buserelintreatmenttoratscausesentericneurodegenerationwithmoderateeffectsoncrfimmunoreactiveneuronsandenterobacteriaceaeincolonandinacetylcholinemediatedpermeabilityinileum AT westrombjorn buserelintreatmenttoratscausesentericneurodegenerationwithmoderateeffectsoncrfimmunoreactiveneuronsandenterobacteriaceaeincolonandinacetylcholinemediatedpermeabilityinileum AT ekbladeva buserelintreatmenttoratscausesentericneurodegenerationwithmoderateeffectsoncrfimmunoreactiveneuronsandenterobacteriaceaeincolonandinacetylcholinemediatedpermeabilityinileum AT ohlssonbodil buserelintreatmenttoratscausesentericneurodegenerationwithmoderateeffectsoncrfimmunoreactiveneuronsandenterobacteriaceaeincolonandinacetylcholinemediatedpermeabilityinileum |